关注
Kripal Bhalala
Kripal Bhalala
Sun Pharmaceuticals Industries Ltd.
在 sunpharma.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles
A Garg, K Bhalala, DS Tomar
International journal of pharmaceutics 516 (1-2), 120-130, 2017
632017
A novel nanosized phospholipid complex of Biochanin A for improving oral bioavailability: Preparation and in-vitro/in-vivo characterizations
SK Singh, M Rashid, K Bhalala, Y Malik, S Chaturvedi, KSR Raju, ...
Journal of Drug Delivery Science and Technology 61, 102254, 2021
122021
Development and investigation of Artemether loaded binary solid lipid nanoparticles: Physicochemical characterization and In-Situ single-pass intestinal permeability
A Garg, DS Tomar, K Bhalala, M Wahajuddin
Journal of Drug Delivery Science and Technology 60, 102072, 2020
92020
Nanomedicine: emerging trends in treatment of malaria
A Garg, K Bhalala, DS Tomar, M Wahajuddin
Antimicrobial Nanoarchitectonics, 475-509, 2017
82017
DEVELOPMENT AND EVALUATION OF LUMEFANTRINE LOADED SOLID LIPID NANOPARTICLES TO INHIBIT P-GLYCOPROTEIN EFFLUX AND ENHANCE ORAL BIOAVAILABILITY
A GARG, KB BHALALA
2016
系统目前无法执行此操作，请稍后再试。
文章 1–5
共建清朗的网络空间,如遇有害信息,请举报。
本站数据皆整合自互联网公开资源索引,方便科研学术方面查询,并不存储相关数据资源;如对此有异议,请联系我们解决.
© 2023 学术资源搜索   @联系我们 | 申请短期会员 | 数据源提交